Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. 4 Open-market sale General Counsel sold 245 shares at $29.98 ($7,345)
  2. 144 Insider Sale of Securities
  3. 8-K Event Shareholder vote results
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 10-Q Report Quarterly Report
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Executive or director change
  10. ARS Other Annual Report to Security Holders
  11. DEF 14A Proxy Proxy Statement
  12. DEFA14A Proxy Proxy Materials
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 8-K Event Auditor change
  16. 4 Grant or award See Remarks acquired 500,000 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 18 · 353 filings